My clinical and research focuses on the development of new breast cancer radiation therapy technologies and improvements in the utilization of existing technologies.
My breast cancer clinical interests are prone radiation, 3D conformal radiation, intensity modulated radiation therapy, and deep inspiration breath hold for cardiac sparing. In gynecologic cancers, my clinical interests include conformal radiation, intensity modulated radiation therapy, high dose rate intracavitary and interstitial brachytherapy.
My scientific work focuses on the effects of radiation therapy in treating malignancies and side effects associated with brachytherapy, which is treatment that is based on the insertion of radioactive implants directly into the affected tissue. Brachytherapy can negatively impact sexual function and quality of life for women with early-stage endometrial cancer, for example. In my clinical practice and research, I focus on treating the cancer with minimal, if any, side effects such as sexual dysfunction.
I have lectured and published on the different techniques for cardiac sparing for women receiving radiation for left breast cancers, most recently in PLoS One. I have also published on quality-of-life issues for women receiving brachytherapy for gynecologic malignancies. I am participating in national clinical trials for breast and gynecologic malignancies, which are currently accruing to provide patients with the highest quality treatment options. I received an Outstanding Achievement in Patient Services award in 2013 for high patient satisfaction scores.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016
University of Vermont College of Medicine
Indiana University School of Medicine
Ohio State University Wexner Medical Ctr
7/1/2007 - 6/30/2011
Specialties and conditions I treat
- Radiation Oncology
- Gynecologic Cancers
- Breast Cancer
Locations where I practice
More about my work
American Board of Radiology (Subspecialty: Radiation Oncology)
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Quick has reported no financial relationships with medical device, research and/or drug companies.